Home › Epilepsy › Arkansas
Epilepsy clinical trials in Arkansas
5 studies for Epilepsy are looking for participants at sites in Arkansas.
Cities in Arkansas
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Pillar Clinical Research, Bentonville
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07594119A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- Clinical Trials, Inc., Little Rock
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Aug 24, 2026 · NCT06132893A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- University of Arkansas for Medical Sciences, Little Rock
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 10, 2026 · NCT05667142Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- University of Arkansas for Medical Sciences, Little Rock
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jun 9, 2026 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Clinical Trials, Inc., Little Rock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT05716100From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.